With regulation bottlenecks surrounding biotechnology, how do gene-edited crops get from the lab to the farm?


Restrictive regulation of genome-edited crops could limit the future impact of these crops on agriculture. Globally, genome-edited crops are currently regulated with either process-based or product-based approaches, although in some countries the regulatory concepts remain unclear. Process-based regulations focus on the biotechnological processes that are used to alter crop DNA. Conversely, the product-based approach regulates the resulting crop plant and its traits, not the breeding process used to create it.

Most crop biotechnology regulatory frameworks were developed or updated to regulate genetically modified organisms (GMOs). GMOs include exogenous DNA that would rarely be present through natural processes. This use of exogenous DNA has raised public and environmental health concerns, resulting in strict regulations in many countries. Many genome-editing approaches do not, however, lead to the presence of exogenous DNA in the final plant product. Indeed, genome editing …. avoids the introduction of any exogenous DNA during the breeding process.

Related article:  FDA Feed Your Mind project offers 'science-based' answers to questions about GMO safety, regulation

Concerns held by the public can put pressure on government bodies to restrict the application of agricultural biotechnology and to limit scientific innovation. Therefore, scientists, the media, and regulatory bodies should place emphasis on engaging the public in factual discussions regarding the safety of genome-editing. Genome-edited crops could increase consumer acceptance of biotechnology in agriculture because of the lack of transgenes, which are the public’s primary concern.


Read full, original article: Bottlenecks for genome-edited crops on the road from lab to farm

Outbreak Daily Digest
Biotech Facts & Fallacies
Genetics Unzipped
Infographic: Deaths from COVID-19 are far higher than reported estimates

Infographic: Deaths from COVID-19 are far higher than reported estimates

More than 2.8 million people have lost their lives due to the pandemic, according to a Wall Street Journal analysis ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

Optional. Mail on special occasions.
Send this to a friend